Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 1 (January)

1. DNA microarray analysis of pancreatic malignancies.
   Pancreatology, 4(6): 587-97. [Abstract] [Full-text]
2. Cell death pathways in pancreatitis and pancreatic cancer.
   Pancreatology, 4(6): 567-86. [Abstract] [Full-text]
3. The role of extended resection in pancreatic adenocarcinoma: is there good evidence-based justification?
   Pancreatology, 4(6): 561-6. [Abstract] [Full-text]
4. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells.
   J Cell Physiol, 202(3): 880-90. [Abstract] [Full-text]
5. Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway.
   Oncogene, 24(1): 199-211. [Abstract] [Full-text]
6. Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.
   Cancer Lett, 218(1): 53-62. [Abstract] [Full-text]
7. Giant insulinoma: case report and review of the literature.
   J Clin Endocrinol Metab, 90(1): 575-80. [Abstract] [Full-text]
8. Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer.
   Cancer Immunol Immunother, 54(3): 254-64. [Abstract] [Full-text]
9. Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion.
   J Surg Res, 123(1): 96-101. [Abstract] [Full-text]
10. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
    Cancer Cell, 7(1): 39-49. [Abstract] [Full-text]
11. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups.
    Cancer, 103(2): 349-57. [Abstract] [Full-text]
12. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas.
    Am J Gastroenterol, 100(1): 144-52. [Abstract] [Full-text]
13. The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease.
    Surgery, 136(6): 1205-11. [Abstract] [Full-text]
14. Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter.
    Cancer Gene Ther, 12(2): 109-15. [Abstract] [Full-text]
15. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Oncogene, 24(4): 662-71. [Abstract] [Full-text]
16. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
    Oncogene, 24(4): 585-96. [Abstract] [Full-text]
17. Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas.
    Virchows Arch, 446(1): 41-5. [Abstract] [Full-text]
18. Autopsy case of CD4/CD8 cutaneous T-cell lymphoma presenting disseminated pagetoid reticulosis with aggressive granulomatous invasion to the lungs and pancreas.
    Pathol Int, 55(1): 32-9. [Abstract] [Full-text]
19. Paratesticular mucinous cystadenocarcinoma: metastasis from pancreatic cancer.
    Int J Urol, 11(12): 1147-9. [Abstract] [Full-text]
20. Spontaneous rupture of varicocele testis associated with advanced pancreatic cancer.
    Int J Urol, 11(12): 1145-6. [Abstract] [Full-text]
21. Phase II study of troxacitabine in chemotherapy-naive patients with advanced cancer of the pancreas: gastrointestinal tumors.
    Ann Oncol, 16(2): 289-93. [Abstract] [Full-text]
22. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells.
    J Surg Oncol, 89(2): 79-85. [Abstract] [Full-text]
23. Magnetic resonance imaging in an orthotopic rat model: blockade of epidermal growth factor receptor with EMD72000 inhibits human pancreatic carcinoma growth.
    Int J Cancer, 114(1): 131-8. [Abstract] [Full-text]
24. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.
    Surgery, 137(2): 192-9. [Abstract] [Full-text]
25. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.
    Oncogene, 24(5): 850-8. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.